인쇄하기
취소

KFDA unveils first study results of isopropylantipyrine

Published: 2012-03-23 06:58:00
Updated: 2012-03-23 06:58:00
The Korea Food and Drug Administration (KFDA) Wednesday unveiled the first results of its ongoing investigation into the safety of isopropylantipyrine (IPA).

No new safety concerns have been raised by a review of adverse events reported in people taking analgesics containing IPA, a substance that has been linked to side effects including aplastic anemia and agranulocytosis, according to the ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.